OREXIA
Orexia is developing oral orexin positive modulators for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal sleep-wake cycle
OREXIA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.orexiatherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF GoDaddy DNS Google Google Cloud Mimecast
Current Employees Featured
Founder
Investors List
Medicxi
Medicxi investment in Seed Round - Orexia
Official Site Inspections
http://www.orexiatherapeutics.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Orexia"
Orexia - Crunchbase Company Profile & Funding
Orexia is developing oral orexin positive modulators for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to โฆSee details»
Orexia Company Profile 2024: Valuation, Investors, Acquisition
Orexia General Information Description. Developer of oral orexin positive modulators designed for the treatment of narcolepsy. The company's modulators develop oral therapies based on โฆSee details»
Orexia Therapeutics - LinkedIn
Orexia Therapeutics | 513 followers on LinkedIn. Developing orexin agonists and positive modulators for the treatment of neurological disorders | Orexia is developing orexin receptor โฆSee details»
Orexia - Products, Competitors, Financials, Employees, โฆ
Orexiatherapeutics.com. Overview & Products; Financials; People; Founded Year 2019. Stage Merger | Merged. About Orexia. Orexia aims to develop orally administered orexin-positive โฆSee details»
Orexia Therapeutics Overview | SignalHire Company Profile
Orexia Therapeutics is a private company. The company currently specializes in the Biotechnology, Biotechnology areas. Its headquarters is located at London, England, GBSee details»
Company Information - RocketReach
Orexia is developing orexin receptor agonists for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal sleep-wake cycle Orexin, also โฆSee details»
Orexia Company Profile - Office Locations, Competitors, Revenue โฆ
Orexia is a biotechnology company that develops oral orexin positive modulators for the treatment of neurological diseases. The modulators aim to restore orexin levels in the brain and improve โฆSee details»
Orexia Therapeutics - Drug pipelines, Patents, Clinical trials
Explore Orexia Therapeutics with its drug pipeline, therapeutic area, technology platform, 8 news, Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug, โฆSee details»
Orexia Therapeutics - VentureRadar
Orexia Therapeutics VentureRadar profile. Find out more about Orexia Therapeutics, Biotech.See details»
Orexia Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Orexia - Centessa Therapeutics (NASDAQ:CNTA) - Medicxi
Orexia aims to develop orally administered orexin positive modulators for the treatment of neurological diseases. The orexin system is a key regulator of behavioural arousal, โฆSee details»
OREXIA THERAPEUTICS LIMITED - Legal Entities - Tracxn
Oct 22, 2024 OREXIA THERAPEUTICS LIMITED is the legal entity of Orexia. You are being shown a subset of the data for this profile.See details»
Orexia therapeutics - Email Address & Phone Number - Lusha
Www.orexiatherapeutics.com. Orexia is developing orexin receptor agonists for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal โฆSee details»
Overview, Competitors & Emplyee insight - AroundDeal
Knowledge Base. Learn how to use AroundDeal effectively and get help when you need itSee details»
Homepage - Centessa Pharmaceuticals
Patient-Centric Mission. Asset-Centric Approach. Weโre pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake, โฆSee details»
Sosei Heptares spin-off company Orexia Therapeutics merged into โฆ
Feb 16, 2021 Sosei Heptares spin-off company Orexia Therapeutics merged into newly created Centessa Pharmaceuticals - Centessa combines 10 privately held biotech companies with โฆSee details»
Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics,
Oct 18, 2021 Centessa Pharmaceuticals Subsidiary, Orexia Therapeutics, and Schrödinger Announce Collaboration to Discover Novel Orexin Receptor AgonistsSee details»
Orexia Therapeutics (Orexia Therapeutics) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ โฆ
~ Announced positive topline data from proof-of-concept study of SerpinPC in severe hemophilia A and B subjects not on prophylaxis, demonstrating 88% reduction in median Annualized โฆSee details»
XโChem Announces Achievement of Milestone In Orexia โฆ
Jul 22, 2020 www.orexiatherapeutics.com. About X-Chem. X-Chem, Inc. is a privately-owned biotechnology company based in Waltham, Massachusetts. The companyโs mission is to apply โฆSee details»
Orexia Therapeutics describes new orexin OX2 receptor agonists
Sep 26, 2023 Orexia Therapeutics Ltd. has identified bicyclic-heterocycle derivatives acting as orexin OX2 receptor agonists. As such, they are reported to be useful for the treatment of โฆSee details»